Respiratory nurse lead Carol Stonham outlines what nurses in primary care need to know about changes in the diagnosis and ...

This big reduction in allergic tissue-resident memory T cells made a difference. Mice were protected against asthma exacerbations for weeks after either treatment, even when they were challenged ...

its use is restricted within the allergic asthma subtype. The treatment of an already established exacerbation is more straight forward than its prevention. It comprises of oxygenation ...

In the SWIFT and ANCHOR trials, depemokimab demonstrated statistically significant reductions in nasal polyp size, ...

In this randomized, placebo-controlled replicate trial, depemokimab decreased the annual rate of exacerbations among patients ...

Asthma isn’t curable, but treatment can help. Consider talking with a family doctor first to learn more about your condition. If needed, the doctor can refer you to a specialist for treatment.

The FDA approval of Airsupra permits use for as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in people with asthma aged 18 years and older.

Asthma a chronic respiratory condition may be driven by specific immune cells that influence inflammation and severity ...

In the emergency room, Cole appeared blue, the suit says, and was given emergency treatment but “despite ... describes as “an extreme form of asthma exacerbation” The lawsuit describes ...

The U.S. Food and Drug Administration (FDA) has accepted GlaxoSmithKlines (NYSE:GSK) biologics license application for ...

Researchers found increased odds for clinical remission on dupilumab with high blood eosinophil and fractional exhaled nitric ...

A team of researchers have discovered a new 'cocktail' of drugs that could help those with asthma and other respiratory ...